RxDoctor Payments DataLook up a doctor →

Michael Fuchs

Gastroenterology · Richmond, VANPI 1487730420

Payments from drug & device makers

$1,920,010in general payments, 2019–2025

Across 772 payments — averaging $2487.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Madrigal Pharmaceuticals$398K
  • E.r. Squibb & Sons, L.L.C.$289K
  • AbbVie$232K
  • Intercept Pharmaceuticals, Inc.$164K
  • Novo Nordisk AS$128K
  • GSK$125K
  • plus $585K from 14 others
$2,533in research payments, 2019–2025

Across 6 payments — averaging $422.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2K
  • Novo Nordisk AS$121
  • Gilead$78
  • GSK$23

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,920,010 in reported general payments places this provider in the 95th percentile of 473 gastroenterology providers in Virginia.

See all gastroenterology providers in Virginia

Other gastroenterology in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →